HDAC9 and prostate cancer: We have also shown that oncolytic Ad5 viruses with the PPT promoter selectively reduce cell viability of prostate cancer cell lines [20], [41] and we therefore wanted to study the putatively additive effect of adding HDAC inhibitors.